Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 7/20 | 0.69 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.69 |
| ▸ | PAM | P19021 | 1/20 | 0.49 |
| ▸ | PRNP | P04156 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4542367 | 1.00 | MTNR1A (0.69) | MTNR1AMTNR1BPAMPRNPNPSR1 | |
| SCHEMBL11552778 | 0.89 | MTNR1A (0.54) | MTNR1AMTNR1BPAMPRNPNPSR1 | |
| SCHEMBL10976954 | 0.86 | MTNR1A (0.63) | MTNR1AMTNR1BPAMRXFP1MMP13 | |
| SCHEMBL10976956 | 0.86 | MTNR1A (0.63) | MTNR1AMTNR1BPAMRXFP1MMP13 | |
| SCHEMBL1158188 | 0.86 | PRNP (0.57) | MTNR1AMTNR1BPRNPNPSR1RXFP1 | |
| SCHEMBL7290207 | 0.85 | MTNR1A (0.51) | MTNR1AMTNR1BPAMPRNPNPSR1 | |
| SCHEMBL7924179 | 0.84 | MTNR1A (0.53) | MTNR1AMTNR1BFFAR1KDM4EMAPT | |
| SCHEMBL11004997 | 0.83 | PRNP (0.51) | MTNR1AMTNR1BPAMPRNPNPSR1 | |
| SCHEMBL11004988 | 0.83 | PRNP (0.51) | MTNR1AMTNR1BPAMPRNPNPSR1 | |
| SCHEMBL28910863 | 0.81 | ACE (0.49) | MTNR1AMTNR1BPRNPNPSR1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011401-A | Photo-responsive brush-shaped macromolecular emulsifier and preparation method thereof | 奇瑞汽车股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260062367-A1 | EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS | MASSACHUSETTS INST TECHNOLOGY (US) | 2026-03-05 | — | — | US | claimed |
| EP-4662099-A1 | APPARATUS FOR SECURING AT LEAST ONE SENSOR DEVICE TO A RAIL OF A RAILWAY TRACK INSTALLATION | Siemens Mobility GmbH (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4084830-B1 | BIOACTIVE PLASTICS WITH PROGRAMMABLE DEGRADATION AND MICROPLASTIC ELIMINATION | UNIV CALIFORNIA (US) | 2025-12-10 | — | — | EP | claimed |
| US-12454501-B2 | Evolving random heteropolymers towards catalytically active materials | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-10-28 | — | — | US | claimed |
| CN-120137239-A | Preparation method of plaque display type caries preventing invisible appliance based on iron-based nano enzyme catalysis and traditional Chinese medicine caries inhibition synergy | 中国医科大学附属口腔医院 | 2025-06-13 | — | — | CN | claimed |
| CN-119324890-B | SPMA protocol design method based on BiLSTM channel load prediction | 北京理工大学 | 2025-04-18 | — | — | CN | claimed |
| WO-2024123469-A9 | EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-04-17 | — | — | WO | claimed |
| CN-119715877-A | Method for detecting cigarette smoke exposure biomarker based on nanofiber solid phase extraction | 东南大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119449599-A | ADS-B information transmission system network design method based on ad hoc network technology | 四川九洲空管科技有限责任公司 | 2025-02-14 | — | — | CN | claimed |
| CN-111830181-A | Fresh chilled meat freshness marker and screening and prediction model fitting method and application thereof | 扬州大学 | 2020-10-27 | — | — | CN | claimed |
| US-20190346449-A1 | BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2019-11-14 | — | — | US | claimed |
| EP-2976061-B1 | COMBINATIONS OF N-ACETYL CYSTEINE DERIVATIVES AND CRANBERRY POLYPHENOLS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PERIODONTAL DISEASES AND PERI-IMPLATITIS | DENTALMED PHARM HOLDING LTD (BE) | 2019-10-16 | — | — | EP | claimed |
| WO-2017214549-A1 | BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-12-14 | — | — | WO | claimed |
| US-20170219570-A1 | Compositions, Apparatus and Methods for Monitoring Biomarkers | Berkeley Test, LLC | 2017-08-03 | — | — | US | claimed |
| EP-2976061-A1 | COMBINATIONS OF N-ACETYL CYSTEINE DERIVATIVES AND CRANBERRY POLYPHENOLS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PERIODONTAL DISEASES AND PERI-IMPLATITIS | Dentalmed Pharm Holding Ltd. (BE) | 2016-01-27 | — | — | EP | claimed |
| EP-2893346-A2 | COMPOSITIONS, APPARATUS AND METHODS FOR MONITORING BIOMARKERS | Berkeley Test LLC (US) | 2015-07-15 | — | — | EP | claimed |
| WO-2014147613-A1 | COMBINATIONS OF N-ACETYL CYSTEINE DERIVATIVES AND CRANBERRY POLYPHENOLS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PERIODONTAL DISEASES AND PERI-IMPLATITIS | DENTALMED PHARM HOLDING LTD. (BE) | 2014-09-25 | — | — | WO | claimed |
| WO-2014039794-A2 | COMPOSITIONS, APPARATUS AND METHODS FOR MONITORING BIOMARKERS | Berkeley Test, LLC (US) | 2014-03-13 | — | — | WO | claimed |
| US-20140065606-A1 | Compositions, Apparatus and Methods for Monitoring Biomarkers | Berkeley Test, LLC (US) | 2014-03-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062367-A1 | EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS | ESD, TET2, HPD | MTNR1A 2914/4885MTNR1B 3888/4885PAM 580/4885 |
| US-12454501-B2 | Evolving random heteropolymers towards catalytically active materials | PNKP, MGAM, HMBS | MTNR1A 4221/4885MTNR1B 4438/4885PAM 1559/4885 |
| US-20190346449-A1 | BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION | BTD, BTF3, PTMS | MTNR1A 1582/4885MTNR1B 2110/4885PAM 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.